In the contralateral cortex, however, the MAP2-labeled dendrites did not show differences between the two stroke groups: the vehicle controls and SCF+G-CSF-treated (Figure S2), suggesting the reparative effects of SCF+G-CSF on chronic stroke. This evidence concerns the gene CSF3 and stroke disorder.